收藏商品
全国免费服务热线
4000-520-616
ATP-dependentK+channel(Kir6,KATP)andCFTRCl-channelblocker.InhibitsKir6currentsinthepancreas,causinganincreaseinintracellularCa2+andinsulinsecretion.InhibitsrecombinantCFTRCl-channelswithanIC50of20μM.
GlibenclamideisalsoofferedaspartoftheTocriscreenPlusandTocriscreenLibraryofFDA-ApprovedCompounds.FindoutmoreaboutcompoundlibrariesavailablefromTocris.
Thetechnicaldataprovidedaboveisforguidanceonly.ForbatchspecificdatarefertotheCertificateofAnalysis.
AllTocrisproductsareintendedforlaboratoryresearchuseonly.
Thefollowingdataisbasedontheproductmolecularweight494.Batchspecificmolecularweightsmayvaryfrombatchtobatchduetosolventofhydration,whichwillaffectthesolventvolumesrequiredtopreparestocksolutions.
Referencesarepublicationsthatsupporttheproducts'biologicalactivity.
Brogdenetal(1979)Glibenclamide:areview.Drugs18329PMID:389600
Robertsonetal(1990)Potassiumchannelmodulators:scientificapplicationsandtherapeuticpromise.J.Med.Chem.331529PMID:2187993
SheppardandWelsh(1992)EffectofATP-sensitiveK+channelregulatorsoncysticfibrosistransmembraneconductanceregulatorchloridechannels.J.Gen.Physiol.100573PMID:1281220
Keywords:Glibenclamide,supplier,K+,channel,blockers,KATP,Blocks,CFTR,Cl-,channels,Potassium,KIR,Inward,Rectifier,Chloride,kir6,Glyburide,Inward,rectifier,Potassium,Channels,CFTR,Inward,rectifier,Potassium,Channels,TocrisBioscience
极简而严谨,我们仅销售188款生物医学科研用品,款款都是爆款;因为少所以聚焦,聚焦甄选每一款产品,聚焦服务每一位客户!
关注我们 :
品质甄选,正品保证
自营电商,厂家直采
极简主义,188精品
公司版权所有 © 2005-2021 苏州蚂蚁淘生物科技有限公司 苏ICP备17049038号-10